PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL
May 1, 2020, 00:00
10.1016/j.jval.2020.04.506
https://www.valueinhealthjournal.com/article/S1098-3015(20)30694-X/fulltext
Title :
PIN34 COST-UTILITY ANALYSIS OF DIRECT ACTING ANTIVIRALS FOR EARLY-STAGE GENOTYPE 1 HCV PATIENTS IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30694-X&doi=10.1016/j.jval.2020.04.506
First page :
Section Title :
Open access? :
No
Section Order :
10385